Skip to content

Enterprise value at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58.42B-29.4%
Stryker logo
StrykerSYK
$137.35B-12.4%
Axogen logo
AxogenAXGN
$1.66B+91.4%
Globus Medical logo
Globus MedicalGMED
$11.21B+15.6%
AbbVie logo
AbbVieABBV
$460.96B+24.7%
Medtronic logo
MedtronicMDT
$131.22B-3.2%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's enterprise value?
Integra LifeSciences (IART) reported enterprise value of $2.47B in Q1 2026.
How has Integra LifeSciences's enterprise value changed year-over-year?
Integra LifeSciences's enterprise value decreased by 26.7% year-over-year, from $3.38B to $2.47B.
What is the long-term trend for Integra LifeSciences's enterprise value?
Over 5 years (2020 to 2025), Integra LifeSciences's enterprise value has grown at a -15.3% compound annual growth rate (CAGR), from $6.06B to $2.64B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.